Birdwatch Note
2024-04-23 14:27:23 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Chemotherapy is among the most effective treatments we have for cancer today. For example, the overall one-year survival rate for cancer patients with advanced head and neck cancers who receive chemotherapy is 52%, compared with 9.5% who do not. https://pubmed.ncbi.nlm.nih.gov/27266222/
Written by 7039222858E466D1613FA74C5284175AAA7AE7FF00201DA93C1B36D6C87E8248
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1782623640543998318
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1782778297748713500
- noteId - 1782778297748713500
- participantId -
- noteAuthorParticipantId - 7039222858E466D1613FA74C5284175AAA7AE7FF00201DA93C1B36D6C87E8248 Participant Details
- createdAtMillis - 1713882443260
- tweetId - 1782623640543998318
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Chemotherapy is among the most effective treatments we have for cancer today. For example, the overall one-year survival rate for cancer patients with advanced head and neck cancers who receive chemotherapy is 52%, compared with 9.5% who do not. https://pubmed.ncbi.nlm.nih.gov/27266222/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-23 14:27:23 UTC (1713882443260) |
2024-04-23 19:17:09 UTC (1713899829373) |
CURRENTLY_RATED_HELPFUL | 2024-04-24 05:51:20 UTC (1713937880601) |
CURRENTLY_RATED_HELPFUL | 2024-04-23 19:17:09 UTC (1713899829373) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-23 19:58:58 -0500 | Rating Details | |
| 2024-04-23 17:23:29 -0500 | Rating Details | |
| 2024-04-23 15:55:25 -0500 | Rating Details | |
| 2024-04-23 13:37:21 -0500 | Rating Details | |
| 2024-04-23 12:42:19 -0500 | Rating Details | |
| 2024-04-23 12:31:57 -0500 | Rating Details | |
| 2024-04-23 12:15:00 -0500 | Rating Details | |
| 2024-04-23 11:04:50 -0500 | Rating Details | |
| 2024-04-23 10:07:40 -0500 | Rating Details | |
| 2024-04-23 09:48:20 -0500 | Rating Details | |
| 2024-04-23 09:40:14 -0500 | Rating Details | |
| 2024-04-23 09:33:57 -0500 | Rating Details | |
| 2024-04-24 18:51:40 -0500 | Rating Details | |
| 2024-04-24 16:26:52 -0500 | Rating Details | |
| 2024-04-24 16:05:05 -0500 | Rating Details | |
| 2024-04-24 15:32:47 -0500 | Rating Details | |
| 2024-04-24 15:31:51 -0500 | Rating Details | |
| 2024-04-24 15:06:17 -0500 | Rating Details | |
| 2024-04-24 13:49:45 -0500 | Rating Details | |
| 2024-04-24 12:36:14 -0500 | Rating Details | |
| 2024-04-24 09:19:24 -0500 | Rating Details | |
| 2024-04-23 21:00:13 -0500 | Rating Details | |
| 2024-04-24 20:22:53 -0500 | Rating Details | |
| 2024-04-24 19:53:38 -0500 | Rating Details | |
| 2024-04-25 02:43:25 -0500 | Rating Details | |
| 2024-04-24 22:27:29 -0500 | Rating Details | |
| 2024-04-24 19:50:40 -0500 | Rating Details | |
| 2024-04-24 19:19:56 -0500 | Rating Details | |
| 2024-04-24 19:03:03 -0500 | Rating Details | |
| 2024-04-24 18:30:18 -0500 | Rating Details | |
| 2024-04-24 15:56:57 -0500 | Rating Details | |
| 2024-04-24 12:41:16 -0500 | Rating Details | |
| 2024-04-24 12:36:51 -0500 | Rating Details | |
| 2024-04-24 12:23:08 -0500 | Rating Details | |
| 2024-04-24 12:16:28 -0500 | Rating Details | |
| 2024-04-24 11:45:00 -0500 | Rating Details | |
| 2024-04-24 11:05:01 -0500 | Rating Details | |
| 2024-04-24 10:59:19 -0500 | Rating Details | |
| 2024-04-24 02:29:51 -0500 | Rating Details | |
| 2024-04-23 21:23:39 -0500 | Rating Details | |
| 2024-04-23 18:16:35 -0500 | Rating Details | |
| 2024-04-23 13:43:49 -0500 | Rating Details | |
| 2024-04-23 12:14:09 -0500 | Rating Details | |
| 2024-04-23 12:06:27 -0500 | Rating Details | |
| 2024-04-23 11:48:10 -0500 | Rating Details | |
| 2024-04-23 11:43:01 -0500 | Rating Details | |
| 2024-04-23 10:41:13 -0500 | Rating Details | |
| 2024-04-23 10:17:14 -0500 | Rating Details | |
| 2024-04-23 09:46:45 -0500 | Rating Details | |
| 2024-04-23 09:41:36 -0500 | Rating Details | |
| 2024-04-23 09:40:13 -0500 | Rating Details | |
| 2024-04-23 09:36:50 -0500 | Rating Details | |
| 2024-04-24 21:12:16 -0500 | Rating Details | |
| 2024-04-24 17:04:49 -0500 | Rating Details | |
| 2024-04-24 16:32:04 -0500 | Rating Details | |
| 2024-04-24 16:07:02 -0500 | Rating Details | |
| 2024-04-24 12:37:25 -0500 | Rating Details | |
| 2024-04-23 22:10:55 -0500 | Rating Details | |
| 2024-04-23 18:40:26 -0500 | Rating Details | |
| 2024-04-23 18:09:40 -0500 | Rating Details | |
| 2024-04-23 16:50:13 -0500 | Rating Details | |
| 2024-04-23 16:17:18 -0500 | Rating Details | |
| 2024-04-23 14:50:49 -0500 | Rating Details | |
| 2024-04-23 13:09:24 -0500 | Rating Details | |
| 2024-04-23 12:34:56 -0500 | Rating Details | |
| 2024-04-23 12:22:56 -0500 | Rating Details | |
| 2024-04-23 10:20:39 -0500 | Rating Details | |
| 2024-04-23 10:15:32 -0500 | Rating Details | |
| 2024-04-23 10:06:52 -0500 | Rating Details | |
| 2024-04-23 10:02:40 -0500 | Rating Details | |
| 2024-04-23 09:54:23 -0500 | Rating Details | |
| 2024-04-23 09:53:15 -0500 | Rating Details | |
| 2024-04-27 21:05:52 -0500 | Rating Details | |
| 2024-04-24 21:40:54 -0500 | Rating Details | |
| 2024-04-24 20:27:20 -0500 | Rating Details | |
| 2024-04-24 16:11:14 -0500 | Rating Details | |
| 2024-04-24 14:28:47 -0500 | Rating Details | |
| 2024-04-24 13:49:22 -0500 | Rating Details | |
| 2024-04-24 13:33:26 -0500 | Rating Details | |
| 2024-04-24 13:11:04 -0500 | Rating Details | |
| 2024-04-24 12:23:01 -0500 | Rating Details | |
| 2024-04-24 12:22:58 -0500 | Rating Details | |
| 2024-04-24 11:36:13 -0500 | Rating Details | |
| 2024-04-24 11:06:31 -0500 | Rating Details | |
| 2024-04-23 20:06:36 -0500 | Rating Details | |
| 2024-04-23 17:40:17 -0500 | Rating Details | |
| 2024-04-23 15:47:17 -0500 | Rating Details | |
| 2024-04-23 14:30:18 -0500 | Rating Details | |
| 2024-04-23 14:02:51 -0500 | Rating Details | |
| 2024-04-23 12:25:50 -0500 | Rating Details | |
| 2024-04-23 12:16:10 -0500 | Rating Details | |
| 2024-04-23 11:43:22 -0500 | Rating Details | |
| 2024-04-23 10:40:52 -0500 | Rating Details | |
| 2024-04-23 10:31:20 -0500 | Rating Details | |
| 2024-04-23 09:37:21 -0500 | Rating Details | |
| 2024-04-23 09:29:44 -0500 | Rating Details | |
| 2024-04-24 16:13:58 -0500 | Rating Details |